Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 374.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 12.00 (3.209%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MaxCyte to consolidate two of its lines of shares

Thu, 13th May 2021 11:22

(Sharecast News) - Cell engineering company MaxCyte announced the consolidation of two of its lines of common stock into a single unrestricted line of common stock on Thursday.
The AIM-traded firm said it would be effected by the transfer of all stock comprising the Regulation S restricted trading line 'MXCL', to the unrestricted common stock trading line 'MXCT'.

It had previously said it intended the two lines of common stock to be consolidated following expiration of the distribution compliance period in relation to new shares on 22 May 2020.

The consolidation was intended to help both trading liquidity and transparency for shareholders, and would result in the cancellation of trading of the Regulation S restricted trading line 'MXCL'.

Currently, MaxCyte common stock is held as unrestricted stock trading under the symbol 'MXCT', and restricted stock trading under the symbols 'MXCL' and 'MXCN'.

The number of unrestricted shares of common stock trading under 'MXCT' is 74,454,534, while there are 9,900,089 restricted shares under 'MXCL' and 330,000 restricted shares under 'MXCN'.

"The consolidation will have a record date of 21 May and will be effective from 24 May, following which 84,354,623 MaxCyte common stock will be held as unrestricted shares in 'MXCT'," the board said in its statement.

"The number of restricted shares of common stock trading under the symbol MXCN will remain as 330,000 for the remainder of the applicable distribution compliance period."

At 1104 BST, shares in MaxCyte were up 0.06% at 892.5p.
More News
8 Dec 2021 15:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
23 Nov 2021 16:21

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares

Read more
23 Nov 2021 15:25

Director dealings: Maxcyte chairman makes share purchase

(Sharecast News) - Maxcyte revealed on Tuesday that chairman Richard Douglas had acquired 20,000 ordinary shares in the AIM-listed cell-engineering company.

Read more
11 Nov 2021 21:26

TRADING UPDATES: iEnergizer and Volex post interim profit hikes

TRADING UPDATES: iEnergizer and Volex post interim profit hikes

Read more
11 Nov 2021 11:58

MaxCyte revenue jumps more than 50pc in third quarter

(Sharecast News) - Commercial cell engineering company MaxCyte reported total third quarter revenue of $10.1m in an update on Thursday, representing 50% growth compared to the same period in 2020.

Read more
3 Nov 2021 14:13

EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers

EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers

Read more
29 Oct 2021 21:20

TRADING UPDATES: Mattioli outlook promising; virus hits Grand Vision

TRADING UPDATES: Mattioli outlook promising; virus hits Grand Vision

Read more
28 Oct 2021 19:19

TRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus

TRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus

Read more
22 Oct 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
1 Oct 2021 17:55

IN BRIEF: MaxCyte Chair Thompson to step down late October

IN BRIEF: MaxCyte Chair Thompson to step down late October

Read more
17 Sep 2021 17:50

IN BRIEF: MaxCyte to join Russell 2000 index in US on September 20

IN BRIEF: MaxCyte to join Russell 2000 index in US on September 20

Read more
14 Sep 2021 17:46

TRADING UPDATES: Strong annual results from Springfield, Fiske

TRADING UPDATES: Strong annual results from Springfield, Fiske

Read more
6 Sep 2021 15:58

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Aug 2021 17:08

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

Read more
2 Aug 2021 21:22

IN BRIEF: MaxCyte underwriters exercise over-allotment option

IN BRIEF: MaxCyte underwriters exercise over-allotment option

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.